...
首页> 外文期刊>Journal of clinical laboratory analysis. >Retraction statement: A kinase‐interacting protein 1 may serve as a potential biomarker for deteriorative tumor features and poor prognosis in gastric cancer patients
【24h】

Retraction statement: A kinase‐interacting protein 1 may serve as a potential biomarker for deteriorative tumor features and poor prognosis in gastric cancer patients

机译:收缩陈述:激酶相互作用蛋白1可以用作潜在的肿瘤特征和胃癌患者预后不良的潜在生物标志物

获取原文
           

摘要

Retraction: A kinase-interacting protein 1 may serve as a potential biomarker for deteriorative tumor features and poor prognosis in gastric cancer patients by Rongbo Lin, Shen Zhao, Liyu Su, Xiaohui Chen, Chunwei Xu, Qinliang He, Changhua Zhuo and Yunbin Ye, J Clin Lab Anal. 2020, 34:e23350 (https://onlinelibrary.wiley.com/doi/10.1002/jcla.23350). The above article, published online on July 16, 2020, in Wiley Online Library has been retracted by agreement between the authors, the journal's Editor-in-Chief, Junming Guo, and Wiley Periodicals, LLC. The retraction has been agreed because upon re-evaluation of the AKIP1 expression data, the authors found that it was originally misread and thus that the conclusions of the study are not valid.
机译:收缩:激酶相互作用蛋白1可以作为潜在的生物标志物,用于历史肿瘤特征和胃癌患者的预后差,沉赵,刘苏,小红陈,春威徐,秦良,昌华卓和云斌, J Clin实验室肛门。 2020,34:e23350(https://onlineLibrary.wiley.com/doi/10.1002/jcla.23350)。 上面的文章于2020年7月16日在线发布,在Wiley在线图书馆签订了作者之间的协议,期刊的主编,君明郭和Wiley期刊,LLC。 已经同意撤回,因为在重新评估AKIP1表达数据时,作者发现它最初是误认为的,因此研究的结论无效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号